- Research works
- 48 ▲ 3820% vs 2013–17
- Citations
- 2.1k 44.9 per fractional work
- Top-10% rate
- 24.6% record average 16.5%
- Open access
- 51% world 28%
Not ranked overall: Beam Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 9.7×. Every wedge is a field page.
Which keywords describe research at Beam Therapeutics (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Cancer Immunotherapy, CAR T Cells, Chimeric Antigen Receptor, Genome Engineering, RNA-Guided, Gene Therapy and Regenerative Medicine.
- Clinical Trials
- Viral Vectors
- AAV
- Gene Therapy
- RNA-Guided
- Chimeric Antigen Receptor
- Cancer Immunotherapy
- Immunotherapy
- CAR T Cells
- Genome Engineering
- Epidemiology
- Regenerative Medicine
- Oxidative Stress
- Inflammation
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 14 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 14 words, with their numbers
- Immunotherapy2▲ 15×3 topics
- Cancer Immunotherapy2▲ 67×2 topics
- CAR T Cells2▲ 119×1 topic
- Chimeric Antigen Receptor2▲ 119×1 topic
- Genome Engineering2▲ 136×1 topic
- RNA-Guided2▲ 136×1 topic
- Epidemiology2▲ 1.73×7 topics
- Gene Therapy2▲ 37×3 topics
- Regenerative Medicine1▲ 23×2 topics
- AAV1▲ 138×1 topic
- Oxidative Stress1▲ 3.5×7 topics
- Viral Vectors1▲ 138×1 topic
- Inflammation1▲ 2.4×9 topics
- Clinical Trials1▲ 6.5×2 topics
Which research topics does Beam Therapeutics (United States) publish most on?
By volume in 2022–2025: CAR-T cell therapy research, CRISPR and Genetic Engineering, Virus-based gene therapy research and Immune Cell Function and Interaction.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 2 works
- 2 CRISPR and Genetic Engineering Molecular Biology 2 works
- 3 Virus-based gene therapy research Genetics 1 works
- 4 Immune Cell Function and Interaction Immunology 1 works
- 5 Hemoglobinopathies and Related Disorders Genetics 1 works
- 6 T-cell and B-cell Immunology Immunology 1 works
- 7 3D Printing in Biomedical Research Biomedical Engineering 1 works
- 8 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 9 Biomedical Ethics and Regulation Physiology 1 works
- 10 Iron Metabolism and Disorders Hematology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Beam Therapeutics (United States)'s research output changed?
Output in 2018–2022 was 3820% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Cambridge
- Harvard University
- Massachusetts Institute of Technology
- Center for Astrophysics Harvard & Smithsonian
- National Bureau of Economic Research
- IIT@MIT
- World Wide Web Consortium
- Broad Institute
- Smithsonian Astrophysical Observatory
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.